Use of Engineered Regulatory T-Cells to Induce Immunologic Tolerance: Path to the Clinic
Time: 3:45 pm
day: Day 2 - Track B - Evening
Details:
• Rational and preliminary data to support the use of antigen-specific Tregs as a therapeutic approach
• Engineering technologies to improve Treg efficacy in the clinical application
